Screener
Pediatrix Medical Group MD Q2 2026 earnings
Reported August 4, 2026 · Before market open
Revenue$487.8MBeat by $9.3M
EPS$0.63Beat by $0.04
Revenue estimate$478.5M
EPS estimate$0.59
“Our strong results this quarter were in line with our expectations and reflect continued favorable trends in the performance of recent acquisitions and same-unit reimbursement metrics. With a coveted, strong balance sheet, we believe we have exceptional financial flexibility to fund organic growth initiatives while remaining well-positioned to pursue potential high-value strategic opportunities.”
Next report
Nov 2, 2026 (In 2 weeks)Revenue estimate$498.2M
EPS estimate$0.65
Valuation & ratios
Valuation
as of 10/12/26Versus estimates
Revenue
Diluted EPS
FAQ
- When did Pediatrix Medical Group report Q2 2026 earnings?
- Pediatrix Medical Group (MD) reported Q2 2026 earnings on August 4, 2026 before market open.
- What were Pediatrix Medical Group's Q2 2026 revenue and EPS?
- Pediatrix Medical Group reported revenue of $487.8M and eps of $0.63 for Q2 2026.
- Did Pediatrix Medical Group beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $478.5M by $9.3M. EPS beat the consensus estimate of $0.59 by $0.04.
- How did Pediatrix Medical Group's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 4.0% from $468.8M a year earlier and eps grew 18.9% from $0.53.
- Where can I find Pediatrix Medical Group's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-331488) and the 10-Q periodic report (0001193125-26-331513) directly on SEC EDGAR. The filing index links above go to sec.gov.
